Telemetry Investments’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $145K | Hold |
4,850
| – | – | 0.23% | 79 |
|
|
2022
Q3 | $162K | Sell |
4,850
-150
| -3% | -$5.01K | 0.21% | 102 |
|
|
2022
Q2 | $200K | Buy |
5,000
+1,650
| +49% | +$66K | 0.24% | 103 |
|
|
2022
Q1 | $176K | Sell |
3,350
-275
| -8% | -$14.4K | 0.28% | 96 |
|
|
2021
Q4 | $201K | Sell |
3,625
-2,900
| -44% | -$161K | 0.26% | 115 |
|
|
2021
Q3 | $505K | Buy |
6,525
+4,525
| +226% | +$350K | 0.68% | 46 |
|
|
2021
Q2 | $260K | Buy |
+2,000
| New | +$260K | 0.36% | 82 |
|
|
2021
Q1 | – | Sell |
-511
| Closed | -$120K | – | 137 |
|
|
2020
Q4 | $120K | Sell |
511
-2,225
| -81% | -$523K | 0.2% | 82 |
|
|
2020
Q3 | $283K | Sell |
2,736
-3,534
| -56% | -$366K | 0.61% | 50 |
|
|
2020
Q2 | $246K | Buy |
6,270
+2,950
| +89% | +$116K | 0.67% | 44 |
|
|
2020
Q1 | $111K | Sell |
3,320
-75
| -2% | -$2.51K | 0.39% | 40 |
|
|
2019
Q4 | $159K | Sell |
3,395
-194
| -5% | -$9.09K | 0.53% | 35 |
|
|
2019
Q3 | $321K | Buy |
3,589
+151
| +4% | +$13.5K | 0.93% | 29 |
|
|
2019
Q2 | $468K | Buy |
3,438
+477
| +16% | +$64.9K | 0.36% | 32 |
|
|
2019
Q1 | $811K | Sell |
2,961
-1,874
| -39% | -$513K | 0.41% | 17 |
|
|
2018
Q4 | $609K | Buy |
4,835
+2,928
| +154% | +$369K | 0.39% | 35 |
|
|
2018
Q3 | $782K | Sell |
1,907
-351
| -16% | -$144K | 0.35% | 22 |
|
|
2018
Q2 | $1.22M | Buy |
+2,258
| New | +$1.22M | 0.46% | 17 |
|